As a tumor promoter, TRIP13 induced the proliferation, migration, invasion, metastasis, and inhibited cell apoptosis of HCC by acting on the TGF-binding 1/smad3 or AKT/mTOR signaling pathway. Here, TRIP13 is linked to neoplasm.